Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001846487-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $77.15 | +21.3K | 106.1K | +25% | +$1.64M | |
| 2026-03-02 | 2026-02-28 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $73.90 | -2,221 | 103.9K | -2% | -$164.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | A | A | 21,306 | $77.15 | 106,146 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-28 | F | D | 2,221 | $73.90 | 103,925 | D | — | — |